Can nifedipine and estrogen interaction with imatinib be responsible for gallbladder stone development?

被引:7
作者
Breccia, M [1 ]
D'Andrea, M [1 ]
Alimena, G [1 ]
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
关键词
D O I
10.1111/j.1600-0609.2005.00476.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:89 / 90
页数:2
相关论文
共 4 条
[1]
[Anonymous], 2004, GLEEV PRESCR INF
[2]
Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function [J].
Blum, A ;
Cannon, RO .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (06) :575-586
[3]
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[4]
Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy [J].
Jukema, JW ;
van der Hoorn, JW .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (02) :459-468